ACVC Premium Access

Type of stent, type of antiplatelet, type of anticoagulant. The triad of success.

Congress Presentation

About the speaker

Doctor Gianni Casella

Maggiore Hospital, Bologna (Italy)
1 presentation
0 follower

4 more presentations in this session

Why do we need to combine antiplatelets and anticoagulants?

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

Rational to remove aspirin from the cocktail. The story after WOEST...(VIA ZOOM)

Speaker: Professor J. ten Berg (Nieuwegein, NL)

Thumbnail

What have we learned in the era of NOACs.

Speaker: Professor F. Verheugt (Amsterdam, NL)

Thumbnail

Ultra-low-dose twice-daily aspirin improves haemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor

Speaker: Doctor W. Parker (Sheffield, GB)

Thumbnail

Access the full session

Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis

Speakers: Doctor G. Casella, Professor R. De Caterina, Professor J. ten Berg, Professor F. Verheugt, Doctor W. Parker
Thumbnail

About the event

Image

Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb